Estimating EuroQol EQ-5D scores from Population Healthy Days data
- PMID: 18556640
- DOI: 10.1177/0272989X07312708
Estimating EuroQol EQ-5D scores from Population Healthy Days data
Abstract
Background: Preference-based assessments of population health, which may be used for cost-utility analyses, are lacking for most states and communities. With adequate population data, preference-based values can be estimated from non-preference-based health-related quality of life (HRQOL) data. This study estimates scores on the EuroQol EQ-5D, a preference-based measure, from the Healthy Days
Methods: No data set from the US population asks both the Healthy Days and EQ-5D questions for the same respondents. Therefore, estimates for EQ-5D scores were obtained indirectly by matching cumulative distributions of the 2 measures. These distributions were estimated from the 2000- 2002 Behavioral Risk Factor Surveillance System (BRFSS) and the Medical Expenditure Panel Survey (MEPS). The validity of estimates was examined by comparing the mean estimated and observed scores across particular population subgroups. A simulation study was conducted to compare the performance of the proposed method to the regression method.
Results: The overall mean observed EQ-5D index was 0.871 and the mean estimated EQ-5D index was 0.872. In the majority of examined subgroups, the mean scores demonstrated a good match according to sociodemographic variables and health-related conditions and, with the exception of the most impaired health states, the differences tended to be less than 0.04.
Conclusions: This study provided preliminary estimates of EQ-5D scores from the Healthy Days Measures and demonstrated acceptable validity of the estimates. Because the Healthy Days Measures have been included in many state and local surveys, preliminary cost-utility analyses and determination of burden of disease might be able to be conducted at the national, state, and community levels as well as over time.
Similar articles
-
An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.Health Econ. 2005 Nov;14(11):1169-89. doi: 10.1002/hec.1006. Health Econ. 2005. PMID: 15942981
-
Predicting EuroQoL EQ-5D preference scores from the SF-12 Health Survey in a nationally representative sample.Med Decis Making. 2004 Mar-Apr;24(2):160-9. doi: 10.1177/0272989X04264015. Med Decis Making. 2004. PMID: 15090102
-
The validity of EQ-5D US preference weights in liver transplant candidates and recipients.Liver Transpl. 2009 Jan;15(1):88-95. doi: 10.1002/lt.21648. Liver Transpl. 2009. PMID: 19109831
-
Outcome after injury-a systematic literature search of studies using the EQ-5D.J Trauma. 2009 Oct;67(4):883-90. doi: 10.1097/TA.0b013e3181ae6409. J Trauma. 2009. PMID: 19820601 Review.
-
The use of the EQ-5D preference-based health status measure in adults with Type 2 diabetes mellitus.Diabet Med. 2011 Apr;28(4):395-413. doi: 10.1111/j.1464-5491.2010.03136.x. Diabet Med. 2011. PMID: 21392061 Review.
Cited by
-
Efficacy, Feasibility, Adherence, and Cost Effectiveness of a mHealth Telerehabilitation Program in Low Risk Cardiac Patients: A Study Protocol.Int J Environ Res Public Health. 2021 Apr 12;18(8):4038. doi: 10.3390/ijerph18084038. Int J Environ Res Public Health. 2021. PMID: 33921310 Free PMC article.
-
Impact of nine chronic conditions for US adults aged 65 years and older: an application of a hybrid estimator of quality-adjusted life years throughout remainder of lifetime.Qual Life Res. 2016 Aug;25(8):1921-9. doi: 10.1007/s11136-016-1226-5. Epub 2016 Jan 18. Qual Life Res. 2016. PMID: 26781442
-
The effects of diabetes, hypertension, asthma, heart disease, and stroke on quality-adjusted life expectancy.Value Health. 2013 Jan-Feb;16(1):140-7. doi: 10.1016/j.jval.2012.08.2208. Epub 2012 Nov 30. Value Health. 2013. PMID: 23337225 Free PMC article.
-
Effect on health-related quality of life of a multimodal physiotherapy program in patients with chronic musculoskeletal disorders.Health Qual Life Outcomes. 2013 Feb 16;11:19. doi: 10.1186/1477-7525-11-19. Health Qual Life Outcomes. 2013. PMID: 23414183 Free PMC article. Clinical Trial.
-
Health, Equity, and Economic Impacts of a Nicotine Product Standard in the United States for People With and Without Major Depression.medRxiv [Preprint]. 2025 Jul 11:2025.07.10.25331302. doi: 10.1101/2025.07.10.25331302. medRxiv. 2025. PMID: 40672485 Free PMC article. Preprint.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources